Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$5.59M Buy
54,702
+21,080
+63% +$2.21M ﹤0.01% 1914
2014
Q2
$3.65M Buy
33,622
+8,625
+35% +$938K ﹤0.01% 2254
2014
Q1
$3.24M Buy
24,997
+2,150
+9% +$343K ﹤0.01% 2280
2013
Q4
$3.13M Buy
22,847
+16,670
+270% +$2.19M ﹤0.01% 2348
2013
Q3
$923K Buy
6,177
+6,010
+3,599% +$1.05M ﹤0.01% 3435
2013
Q2
$28K Buy
+167
New +$20.1K ﹤0.01% 7473

Other funds holding VSTM

UBS's VSTM Position: Q3 2014 in Review

UBS increased its Verastem (VSTM) stake by 63% in Q3 2014, buying an estimated $2.21M and bringing the position to 54,702 shares worth $5.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

UBS first reported a position in VSTM in Q2 2013 and has held it in 6 quarters since. 69 funds tracked by Wall St. Rank hold VSTM as of Q3 2014.

  • UBS held 54,702 shares of Verastem worth $5.59M as of Q3 2014.
  • UBS bought 21,080 Verastem shares in Q3 2014, an estimated $2.21M.
  • Verastem made up ﹤0.01% of UBS's portfolio in Q3 2014, its #1914 holding.
  • UBS first reported a position in Verastem in Q2 2013 and has held it in 6 quarters since.
  • 69 funds tracked by Wall St. Rank held Verastem as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.